← Leaderboards
Anthony James Ocon
New York Medical College
$145,200
Attributed
$145,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.8K · FY2009–12$50K$37.5K$25K$12.5K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$145,200 · 1
By mechanism
F30$145,200 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Medical College
Same institution · by research overlap
- Julian M Stewart$11,849,012
- Zoltan Istvan Ungvari$9,676,884
- Michal Laniado Schwartzman$18,004,835
- Alberto Nasjletti$6,905,477
- Marvin S Medow$805,309
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAmericanBiopsyBloodBlood CirculationBlood FlowBlood VesselsChronicChronic Fatigue SyndromeChronic Orthostatic IntoleranceCutaneousCyclic GmpDependenceFluid OverloadGuanylate CyclaseHeatingHuman Nos2a ProteinHyperemiaHypovolemiaInhibitor/AntagonistLasersLeukocytesMediatingAcetylcholine
Grant awards (4)
Inhibition of NO Dependent Splanchnic Hyperemia Improves CFS/POTS$42,628
F30 · FY2012 · HL · contact PI
Inhibition of NO Dependent Splanchnic Hyperemia Improves CFS/POTS$46,800
F30 · FY2011 · HL · contact PI
Inhibition of NO Dependent Splanchnic Hyperemia Improves CFS/POTS$27,988
F30 · FY2010 · HL · contact PI
Inhibition of NO Dependent Splanchnic Hyperemia Improves CFS/POTS$27,784
F30 · FY2009 · HL · contact PI